Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Want to apply for Canada PR? The country is set to introduce four new permanent residency (PR) pathways in 2025, even as the government plans to reduce its PR targets from 485,000 to 465,000, ...
The world’s richest man raised plenty of eyebrows when he flung his arm up during a post-inauguration rally in Washington, but his supporters say he’s just awkward. Breaking News Reporter ...
The Hubble tension grows: new data shows the Universe’s expansion defies current physics models, suggesting our understanding of cosmology may need a major overhaul. Credit: SciTechDaily.com New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results